Up Next
Back to Show
American Black Journal
FDA approves new gene therapies for sickle cell disease
Host Stephen Henderson examines the groundbreaking new gene therapies approved by the U.S. Food and Drug Administration as a treatment option for sickle cell disease. Dr. Melissa Creary, assistant professor at the University of Michigan’s School of Public Health, sits down with Henderson to talk about the pros, cons and possible barriers of the new gene-editing therapy.
Support Provided By
26:46
A pivotal moment in the history of baseball and the Detroit Women in Jazz Oral History Project.
26:46
The mental health struggles of young African Americans and the challenges and rewards of caregiving.
26:46
Ahead of the Movement Festival, we’re featuring conversations about Detroit’s techno scene.
26:46
How United Way for Southeastern Michigan is helping feed families and more on caregiving.
26:46
A Detroit workshop helps small businesses, and we’ll hear the personal stories of caregivers.
26:46
How churches are tackling the affordable housing shortage and our first "Faith in Detroit" story.
26:46
A preview of Bookstock and sitting down with this year’s Detroit Jazz Festival Artist-in-Residence.
26:46
Eliminating health disparities that put Black mothers at risk and a look at a caregiving event.
26:46
Nonprofit works to improve Detroit neighborhoods and a talk on the state of education in Michigan.
26:46
A look at an initiative that supports women preachers and church leaders.
26:46
This year’s Kresge Eminent Artist, the relationship between Black and Jewish communities in Detroit.
26:46
“The Lion King” is back and a look at civil rights leader Jesse Jackson’s appearance on ABJ in 2015.